Skip to main content
. 2020 Jun 19;12:4747–4758. doi: 10.2147/CMAR.S255866

Figure 1.

Figure 1

Dysregulated HCP5 in colorectal cancer patients. (A) The level of HCP5 in CRC tissues and adjacent normal tissues was examined by RT-qPCR. (B) The expression levels of HCP5 in cells were detected by RT-qPCR. (C) The level of HCP5 in CRC cells was analyzed on TCGA database. (D) The prognosis results of HCP5 was analyzed on TCGA database. N = 3, *P < 0.05, **P < 0.01, ***P < 0.001.